Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants

NCT06690515 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT06690515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06690515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
Lead sponsor
PT Bio Farma
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
September 30, 2026
Enrollment
465 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine adverse reaction, vaccine reaction